Kyushu University Academic Staff Educational and Research Activities Database
Researcher information (To researchers) Need Help? How to update
Hideaki Yahata Last modified date:2018.06.07

Associate Professor / Obstetrics & Gynecology
Department of Clinical Medicine
Faculty of Medical Sciences


Graduate School
Administration Post
Other
Other
Other
Other


E-Mail
Phone
092-642-5395
Fax
092-642-5414
Academic Degree
MD-phD
Country of degree conferring institution (Overseas)
No
Field of Specialization
Gynecological Oncology
Total Priod of education and research career in the foreign country
01years00months
Outline Activities
Gynecologic Oncology
Research
Research Interests
  • Re-assesment of vessel permeation and stromal invasion for risk classification of cervical cancer
    keyword : cervical cancer risk classification
    2018.06~2018.06.
  • Clinical trial of sentinel lymph node navigation surgery with intraoperative diagnosis in cervical cancer
    keyword : cervical cancer SNNS
    2015.07~2018.03.
  • The study of sexual QOL assesment after trachelectomy in young cervical cancer patient
    keyword : QOL cervical cancer tracelectomy
    2014.05~2015.03.
  • Aprepitant for the prevention of chemotherapy-induced nausea and vomiting with a moderately emetogenic chemotherapy: a multicenter, placebo-controlled, double-blind, randomized study in Japanese gynecologic patients receiving paclitaxel and carboplatin.
    keyword : CINV MEC regimen
    2014.04~2015.03.
  • The study of hypersensitive reaction caused by paclitaxel
    keyword : paclitaxel hypersensitivity
    2012.05~2013.12.
  • Clinical trial for gynecologic malignancy
    Clinical research for hypersensitivity reaction in administration of paclitaxel
    Sentinel node navigation for cervical cancer
    keyword : Gynecological Oncology
    2009.04~2011.03.
Academic Activities
Papers
1. Hideaki Yahata, Kenzo Sonoda, Yasunaga Masafumi, Tatsuhiro Ogami, Kaneki Eisuke, Kawano Yoshiaki, Okugawa Kaoru, Tsunehisa Kaku, Kato K, Surgical treatment and outcome of early invasive adenocarcinoma of the uterine cervix (FIGO stage IA1)., Asia Pac J Clin Oncol., 2017.04, Aim: To investigate the surgical outcome of FIGO stage IA1 cervical adenocarcinoma. Methods: Between 2005 and 2011, 12 patients from Kyushu University Hospital had cervical adenocarcinoma, with a tumor depth of less than 3 mm and a horizontal width of less than 7 mm (FIGO stage IA1), diagnosed by cervical conization. All patients underwent simple hysterectomy or simple trachelectomy with pelvic lymphadenectomy. Results: The mean patient age was 34 years (range, 26-70 years). The median follow-up period was 70.5 months (range, 26-99 months). No pelvic lymph-node metastasis was seen, and no patient experienced disease recurrence. Conclusion: Early invasive cervical adenocarcinoma with a depth of invasion of 3 mm or less and a horizontal spread of 7 mm or less has little potential for nodal metastasis or recurrence. Therefore, simple hysterectomy or trachelectomy without lymphadenectomy is an important treatment options for stage IA1 cervical adenocarcinoma..
2. Hideaki Yahata, Hiroaki Kobayashi, Kenzo Sonoda, Mototsugu Shimokawa, Tatsuhiro Ohgami, Toshiaki Saito, Shinji Ogawa, Kunihiro Sakai, Akimasa Ichinoe, Yousuke Ueoka, Yasuyuki Hasuo, Makoto Nishida, Satohiro Masuda, Kiyoko Kato, Efficacy of aprepitant for the prevention of chemotherapy-induced nausea and vomiting with a moderately emetogenic chemotherapy regimen: a multicenter, placebo-controlled, double-blind, randomized study in patients with gynecologic cancer receiving paclit, International Jurnal of Clinical Oncology, 2015.11.
3. H Yahata, M Saito, T Sendo, Y Itoh, M Uchida, T Hirakawa, H Nakano, R Oishi, Prophylactic effect of pemirolast, an antiallergic agent, against hypersensitivity reactions to paclitaxel in patients with ovarian cancer, Int. J. Cancer, 118, 2636-2638(2006), 2006.02.
4. Hideaki Yahata, Hiroaki Kobayashi, Toshiharu Kamura, Toshio Hirakawa, Kimitoshi Kohno, Michihiko Kuwano, Hitoo Nakano, Increased nuclear localization of transcription factor YB-1 in acquired cisplatin resistant ovarian cancer., J Cancer Res Clin Oncol, 2002.06.
Presentations
1. Hideaki Yahata, Sentinel Node Navigation Surgery in Cervical Cancer, 25th Asian and Oceanic Congress of Obstetrics and Gynaecology , 2017.06.
2. Hideaki Yahata, Aprepitant for the prevention of chemotherapy-induced nausea and vomiting with a moderately emetogenic chemotherapy: a multicenter, placebo-controlled, double-blind, randomized study in Japanese gynecologic patients receiving paclitaxel and carboplatin., Europian Society for Medical Oncology 2014, 2014.09.
3. 矢幡 秀昭, Our surgical form and outcome of early invasive adenocarcinoma of the uterine cervix (FIGO 1A1), the 3rd Asian Society of Gynecologic Oncology, 2013.12.
Educational
Educational Activities
Gynecologic benign tumor
Gynecologica malignant tumor